Robert W. Scherrer

Finanzdirektor/CFO bei Genomas, Inc.

Health Services

Consumer Services

Health Technology

Aktive Positionen von Robert W. Scherrer

Unternehmen	Position	Beginn	Ende
Genomas, Inc. Genomas, Inc. Medical/Nursing ServicesHealth Services Genomas, Inc. operates as a biomedical company. It develops revolutionary PhyzioType Systems for DNA-guided management and prescription of drugs to treat mental illness, pain, heart disease, and diabetes. The firm’s products include HILOmet PhyzioType System, PIMS PhyzioType, SINM PhyzioType, and GLIM PhyzioType systems. The company was founded by Gualberto Ruaño in 2004 and is headquartered in Hartford, CT.	Finanzdirektor/CFO	-	-

Unternehmen	Position	Beginn	Ende
Freshnex, Inc.	Geschäftsführer	01.01.1999	01.01.2002
Protein Sciences Corp. Protein Sciences Corp. BiotechnologyHealth Technology Protein Sciences Corp. engages in developing and manufacturing recombinant human and veterinary vaccines, therapeutics and diagnostics. The firm develops vaccines for influenza, SARS and other diseases. The company was founded by Mark A. Cochran and Franklin Volvovitz in 1983 and is headquartered in Meriden, CT.	Geschäftsführer	01.01.1994	01.01.1998
	Präsident	01.01.1994	01.01.1998
Richardson-Vicks, Inc.	Finanzdirektor/CFO	-	-

Temple University (Pennsylvania)

Undergraduate Degree

International

Vereinigte Staaten

Operativ

Sektoral

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Private Unternehmen	4
Genomas, Inc. Genomas, Inc. Medical/Nursing ServicesHealth Services Genomas, Inc. operates as a biomedical company. It develops revolutionary PhyzioType Systems for DNA-guided management and prescription of drugs to treat mental illness, pain, heart disease, and diabetes. The firm’s products include HILOmet PhyzioType System, PIMS PhyzioType, SINM PhyzioType, and GLIM PhyzioType systems. The company was founded by Gualberto Ruaño in 2004 and is headquartered in Hartford, CT.	Health Services
Protein Sciences Corp. Protein Sciences Corp. BiotechnologyHealth Technology Protein Sciences Corp. engages in developing and manufacturing recombinant human and veterinary vaccines, therapeutics and diagnostics. The firm develops vaccines for influenza, SARS and other diseases. The company was founded by Mark A. Cochran and Franklin Volvovitz in 1983 and is headquartered in Meriden, CT.	Health Technology
Richardson-Vicks, Inc.
Freshnex, Inc.